Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Non-small cell lung cancer (NSCLC) Clinical Research Samples

Discovery Life Sciences provides the highest quality Non-small cell lung cancer (NSCLC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Non-small cell lung cancer (NSCLC) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 17 of 17 total samples
 (0)
Checkout
Advanced Data View:
Showing 17 of 17 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Test 3Test Data 3Detail 3Product
Details
Price
Buy
Blood TypeCurrent MedicationsSmoking NotesICD10 codesSite of Primary TumorSite of MetastasisHistory of Benign Disease Prior to Cancer DiagnosisAny Previous Form of CancerBiomarker testing Information
BBS0000-M2900100785100218DDNon-small cell lung cancer (NSCLC)United StatesSerum1.006.00$250.0075 YFemaleNon-Hispanic<-70C02-Oct-18Clinical DiagnosisMetastatic NSCLCAny Previous Form of Cancer?NoDate of Initial Primary Tumor Diagnosis26-Apr-16$250.00UnknownAzithromycin, dexamthasone, diltiazem, folic acid, hydrochlorothiazide, levothyroxine, medical marijuana, Medrol Dosepak, metformin, protonix, warfarinPrevious- 60-pack-yearsRight lungBilateral Lung, possibly boneHypertension, type II diabetes, hypothyroidismNoCEA: 5.1 ng/Ml
BBS0000-Y9900111010021017DDNon-small cell lung cancer (NSCLC)United StatesSerum1.003.00$250.0061 YFemaleNon-Hispanic<-70C10-Feb-17Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingStage I, T1N0M0,10-Feb-17Date of Initial Primary Tumor Diagnosis18-Jan-17$250.00UnknownAlbuterol, Norvasc, Aspirin, Symbicort, Klonopin, Lexapro, Flonase, HydroDIURIL, Duoneb, Lisinopril, Claritin, Lopressor, Singulair, Centrum Silver, Prilosec, Spiriva , Zanaflex | Hepatitis CFormer 2 packs/day for 46 yearsUpper Lobe Mass in Right LungN/AN/ANoBRAF-V600E, Negative for mutation 20-Jan-2017 | KRAS Mutational Analysis: Mutation Identified 20-Jan-2017
BBS0005-AA900061078072816DDNon-small cell lung cancer (NSCLC)Russia0.5 mL Serum1.001.00$250.0046 YMaleNon-Hispanic<-70C28-Jul-16Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingII; T2N1M0G33-Aug-16Date of Initial Primary Tumor Diagnosis12-Jul-16$250.00UnknownNoneCurrent; 15-20 per dayLeft LungN/ANoNoN/A
BBS0005-AA900061090072116DDNon-small cell lung cancer (NSCLC)Russia0.5 mL Serum3.00$250.0054 YMaleNon-Hispanic<-70C21-Jul-16Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingII; T2N0M0G226-Jul-16Date of Initial Primary Tumor Diagnosis13-Jul-16$250.00UnknownNoneCurrent; 20-30 per dayRight LungN/ANoNoN/A
BBS0005-AA900061091072216DDNon-small cell lung cancer (NSCLC)Russia0.5 mL Serum1.001.00$250.0077 YMaleNon-Hispanic<-70C22-Jul-16Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingII; T2N0M0G326-Jul-16Date of Initial Primary Tumor Diagnosis7-Jul-16$250.00UnknownNoneCurrent; 10-30 per dayLeft LungN/ANoNoN/A
BBS0005-AA900061092102016DDNon-small cell lung cancer (NSCLC)Russia0.5 mL Serum1.002.00$250.0060 YFemaleNon-Hispanic<-70C20-Oct-16Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingII; T2N0M0G325-Oct-16Date of Initial Primary Tumor Diagnosis7-Oct-16$250.00UnknownNoneCurrent; 10-20 per dayRight LungN.ANoNoN/A
BBS0005-AA900061093070816DDNon-small cell lung cancer (NSCLC)Russia0.5 mL Serum1.001.00$250.0065 YMaleNon-Hispanic<-70C08-Jul-16Clinical DiagnosisNon Small Cell Lung CancerPre-TreatmentStagingIII; T3N1M0G413-Jul-16Date of Initial Primary Tumor Diagnosis21-Jun-16$250.00UnknownNoneCurrent; 20-30 per dayRight LungN/ANoNoN/A
BBS0005-M2900020371092118DDNon-small cell lung cancer (NSCLC)United States0.5 mL Serum1.009.00$250.0061 YFemaleNon-Hispanic<-70C21-Sep-18Clinical DiagnosisNSCLCAny Previous Form of Cancer?BreastDate of Initial Primary Tumor Diagnosis27-Apr-18$250.00UnknownAmitriptylene, calcium, cyclobenzaprine, folic acid, medical marijuana, neurontin, ondansetron, oxycodone, percocet, prochlorperazineCurrentmedial aspect of right upper lobeNAOsteoarthritis, carpal tunnel syndrome, peptic ulcer disease, IBSBreastNone
BBS0005-M2900020373092618DDNon-small cell lung cancer (NSCLC)United States0.5 mL Serum1.002.00$250.0063 YFemaleNon-Hispanic<-70C26-Sep-18Clinical DiagnosisNSCLCAny Previous Form of Cancer?NoDate of Initial Primary Tumor Diagnosis18-Aug-15$250.00UnknownCBD, docusate sodium, levothyroxine, lexapro, lorazepam, lyrica, multivitamin, nasal saline, ProAir, Restoril, simvastatin, Voltaren, ZofranCurrent- 40-pack-yearsright upper lobemediastinum, retroperitoneum, lymph nodes, bilateral neck, chest, peripancreatic areaFibromyalgia, hyperlipemia, COPDNoNone
BBS0005-M2900020374111518DDNon-small cell lung cancer (NSCLC)United States0.5 mL Serum1.003.00$250.0065 YMaleUnknown<-70C15-Nov-18Clinical DiagnosisNSCLCStagingT3NxMx27-Jul-18Date of Initial Primary Tumor Diagnosis4-Feb-13$250.00UnknownAcetaminophen, dexamethasone, hydrocodone, ibuprofen, lorazepam, ondansetron, proAir, prochlorperazinePrevious, 90-pack-yearsRight Upper Lobe and Right Lower Lobe- 2 separate primariesU/Atype II diabetes, CAD, hypertension, dyslipidemiaU/AU/A
BBS0005-M2900020564082418DDNon-small cell lung cancer (NSCLC)United States0.5 mL Serum1.002.00$250.0049 YFemaleNon-Hispanic<-70C24-Aug-18Clinical DiagnosisNSCLCMost Recent StagingT1N2M0Date of Initial Primary Tumor Diagnosis4/28/2018$250.00UnknownOmeprazole 20mg, Keppra 500mg, Topamax 100mg, LaMICtal150mg, LaMICtal 100mgCurrent; 48-pack-yearsRight Middle Lobe of LungU/AU/AYes; NSCLC 08/2016
BBS0005-P6900088866012519DDNon-small cell lung cancer (NSCLC)United States0.5 mL Serum1.009.00$250.0071 YFemaleNon-Hispanic<-70C25-Jan-19Clinical DiagnosisNon-small cell lung cancer (adenosquamous histology)StagingIb; T2N0M08-Nov-18Date of Initial Primary Tumor Diagnosis23-Oct-18$250.00UnknownWarfarin, Albuterol, Amiodarone, Amlodipine, Aspirin, Atorvastatin, Calcium carbonate, Doxycycline, Gabapentin, Metoprolol tartrate, Prednisone, Eye Vitamin and MineralsFormer 2 packs/day for 43 yearsRight lung, upper lobeN/ANoNoNone
EDP0000-AA900040117112017DDNon-small cell lung cancer (NSCLC)RussiaK2 EDTA Plasma1.001.00$250.0067 YFemaleNon-Hispanic<-70C20-Nov-17Clinical DiagnosisAdenocarcinomaPre-TreatmentStagingIIIa; T3N2M0G326-Nov-17Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT2-Nov-17$250.00UnknownL-Thyroxine, Diltiazem, EnalaprilNoneC34.11Right lung, (upper lobe)N/ANoNoNone
EDP0000-AA900082617090817DDNon-small cell lung cancer (NSCLC)RussiaK2 EDTA Plasma1.002.00$250.0071 YFemaleNon-Hispanic<-70C08-Sep-17Clinical DiagnosisSquamous Cell Lung CarcinomaPre-TreatmentStagingStage Iib; T3N0M0G213-Sep-17Date of Initial Primary Tumor Diagnosis15-Aug-17$250.00UnknownN/ANoneC34.11Right lung (lower lobe)N/ANoNoNone
EDP0000-AA900082619073117DDNon-small cell lung cancer (NSCLC)RussiaK2 EDTA Plasma1.002.00$250.0064 YMaleNon-Hispanic<-70C31-Jul-17Clinical DiagnosisSquamous Cell Lung CarcinomaPre-TreatmentStagingStage IIIb; T4N2M0G23-Aug-17Date of Initial Primary Tumor Diagnosis18-Jul-17$250.00UnknownN/ACurrent 10-15 cigs/day for 40 yearsC34.11Right lung (upper lobe)N/AChronic BronchitisNoNone
EDP0000-AA900082620072517DDNon-small cell lung cancer (NSCLC)RussiaK2 EDTA Plasma1.001.00$250.0061 YMaleNon-Hispanic<-70C25-Jul-17Clinical DiagnosisBronchoalveolar AdenocarcinomaPre-TreatmentStagingStage Iib; T2N1M0G128-Jul-17Date of Initial Primary Tumor Diagnosis10-Jul-17$250.00UnknownN/ACurrent 10-20 cigs/day for 30 yearsC34.11Right lungN/AChronic BronchitisNoNone
RUI0000-AI900019043082819DDNon-small cell lung cancer (NSCLC)United StatesRaw Urine3.501.00$75.0062 YMaleNon-Hispanic<-70C28-Aug-19DiagnosisNon Small Cell CarcinomaPre-Treatment$75.00Unknown

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.